286 related articles for article (PubMed ID: 24886691)
1. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
[TBL] [Abstract][Full Text] [Related]
2. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Ruparelia K
Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327
[TBL] [Abstract][Full Text] [Related]
3. Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS).
Abioye AO; Chi GT; Simone E; Nagy Z
Int J Pharm; 2016 Jul; 509(1-2):264-278. PubMed ID: 27260131
[TBL] [Abstract][Full Text] [Related]
4. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
Abioye AO; Kola-Mustapha A
Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
[TBL] [Abstract][Full Text] [Related]
5. Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs.
Abioye AO; Kola-Mustapha A
Pharm Res; 2015 Jun; 32(6):2110-31. PubMed ID: 25527142
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic Changes Induced by Intermolecular Interaction Between Ibuprofen and Chitosan: Effect on Crystal Habit, Solubility and In Vitro Release Kinetics of Ibuprofen.
Abioye AO; Armitage R; Kola-Mustapha AT
Pharm Res; 2016 Feb; 33(2):337-57. PubMed ID: 26404641
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties.
Jiang B; Hu L; Gao C; Shen J
Int J Pharm; 2005 Nov; 304(1-2):220-30. PubMed ID: 16182477
[TBL] [Abstract][Full Text] [Related]
8. Development of aqueous ternary nanomatrix films: A novel 'green' strategy for the delivery of poorly soluble drugs.
Kola-Mustapha AT; Armitage D; Abioye AO
Int J Pharm; 2016 Dec; 515(1-2):616-631. PubMed ID: 27825861
[TBL] [Abstract][Full Text] [Related]
9. Influence of processing methods on physico-mechanical properties of Ibuprofen/HPC-SSL formulation.
Chaturvedi K; Gajera BY; Xu T; Shah H; Dave RH
Pharm Dev Technol; 2018 Dec; 23(10):1108-1116. PubMed ID: 29310491
[TBL] [Abstract][Full Text] [Related]
10. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
11. Non-intuitive Behavior of Polymer-Ciprofloxacin Nanoconjugate Suspensions: a Tool for Flexible Oral Drug Delivery.
Abioye A; Naqvi M; Pattni D; Adepoju-Bello AA
AAPS PharmSciTech; 2021 Aug; 22(7):229. PubMed ID: 34467444
[TBL] [Abstract][Full Text] [Related]
12. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs.
Zhang P; Forsgren J; Strømme M
Int J Pharm; 2014 Sep; 472(1-2):185-91. PubMed ID: 24950364
[TBL] [Abstract][Full Text] [Related]
13. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone.
Mohammadi G; Barzegar-Jalali M; Valizadeh H; Nazemiyeh H; Barzegar-Jalali A; Siahi Shadbad MR; Adibkia K; Zare M
J Pharm Pharm Sci; 2010; 13(2):152-61. PubMed ID: 20816002
[TBL] [Abstract][Full Text] [Related]
15. Precipitation of Ibuprofen Sodium using compressed carbon dioxide as antisolvent.
Bakhbakhi Y; Alfadul S; Ajbar A
Eur J Pharm Sci; 2013 Jan; 48(1-2):30-9. PubMed ID: 23127825
[TBL] [Abstract][Full Text] [Related]
16. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
20. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]